SAGE - Sage Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.98B
Enterprise Value 36.46B
Trailing P/E N/A
Forward P/E 1-14.11
PEG Ratio (5 yr expected) 1-0.92
Price/Sales (ttm)88.41
Price/Book (mrq)8.52
Enterprise Value/Revenue 371.53
Enterprise Value/EBITDA 6-16.47

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-435.61%

Management Effectiveness

Return on Assets (ttm)-33.15%
Return on Equity (ttm)-55.72%

Income Statement

Revenue (ttm)90.27M
Revenue Per Share (ttm)1.96
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-191.83M
EBITDA -392.1M
Net Income Avi to Common (ttm)-372.88M
Diluted EPS (ttm)-8.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)922.78M
Total Cash Per Share (mrq)19.59
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.98
Book Value Per Share (mrq)18.41

Cash Flow Statement

Operating Cash Flow (ttm)-260.67M
Levered Free Cash Flow (ttm)-127.14M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.04
52-Week Change 3-3.51%
S&P500 52-Week Change 37.38%
52 Week High 3188.82
52 Week Low 379.88
50-Day Moving Average 3153.99
200-Day Moving Average 3130.84

Share Statistics

Avg Vol (3 month) 3654.28k
Avg Vol (10 day) 3593.28k
Shares Outstanding 550.93M
Float 45.72M
% Held by Insiders 12.71%
% Held by Institutions 198.48%
Shares Short (Feb 28, 2019) 44.21M
Short Ratio (Feb 28, 2019) 47.06
Short % of Float (Feb 28, 2019) 412.89%
Short % of Shares Outstanding (Feb 28, 2019) 48.27%
Shares Short (prior month Jan 31, 2019) 44.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A